Tadaatsu Imaizumi Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2017	DEC1 promotes hypoxia-induced epithelial-mesenchymal transition (EMT) in human hepatocellular carcinoma cells.
5/2014	Phosphorylation of serine 349 of p62 in Alzheimer's disease brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadaatsu Imaizumi Research Topics

Disease

22	Virus Diseases (Viral Diseases) 11/2022 - 08/2004
22	Melanoma (Melanoma, Malignant) 02/2022 - 09/2005
15	Inflammation (Inflammations) 01/2024 - 01/2006
14	Lupus Nephritis 12/2023 - 08/2007
13	Hypoxia (Hypoxemia) 01/2017 - 04/2002
9	Glomerulonephritis 12/2023 - 03/2008
9	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 06/2002
8	Neoplasms (Cancer) 01/2020 - 04/2002
8	Astrocytoma (Pilocytic Astrocytoma) 01/2018 - 06/2007
7	Neuroblastoma 04/2024 - 02/2013
6	Infections 01/2022 - 01/2007
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2022 - 04/2019
4	Chronic Renal Insufficiency 09/2021 - 01/2017
4	Parkinson Disease (Parkinson's Disease) 10/2015 - 06/2002
3	Rheumatoid Arthritis 01/2024 - 01/2009
3	Aortic Valve Stenosis (Aortic Stenosis) 02/2021 - 11/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 10/2015
3	Atherosclerosis 01/2017 - 04/2007
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 10/2017
2	Thrombosis (Thrombus) 01/2020 - 04/2019
2	Nephritis 01/2018 - 12/2011
2	Purpura 01/2018 - 12/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 05/2014
2	IGA Glomerulonephritis (IGA Nephropathy) 12/2015 - 10/2015
2	Neuroinflammatory Diseases 05/2015 - 07/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2014 - 01/2006
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2012 - 02/2011
2	Carcinoma (Carcinomatosis) 07/2007 - 08/2004
2	Necrosis 01/2006 - 12/2002
2	Mouth Neoplasms (Oral Cancer) 01/2006 - 05/2004
1	Central Nervous System Viral Diseases 04/2024
1	Osteoarthritis 01/2024
1	Obesity 03/2023
1	Endotoxemia 03/2023

Drug/Important Bio-Agent (IBA)

27	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2022 - 08/2004
18	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2002
15	Toll-Like Receptor 3IBA 01/2024 - 01/2013
15	Antiviral Agents (Antivirals)IBA 12/2023 - 09/2005
15	Poly I-CIBA 01/2021 - 08/2004
12	InterferonsIBA 12/2023 - 02/2007
12	Messenger RNA (mRNA)IBA 01/2022 - 04/2002
9	RNA Helicases (RNA Helicase)IBA 01/2024 - 07/2006
9	Interferon Type IIBA 12/2022 - 07/2008
9	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2019 - 08/2004
8	ChemokinesIBA 04/2024 - 01/2006
7	CytokinesIBA 12/2019 - 02/2007
6	Chemokine CX3CL1IBA 11/2020 - 12/2002
6	Amyloid beta-PeptidesIBA 01/2018 - 06/2002
6	Amyloid (Amyloid Fibrils)IBA 01/2018 - 06/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2008 - 07/2002
5	Viral RNAIBA 01/2019 - 09/2005
5	Peptides (Polypeptides)IBA 01/2018 - 02/2013
4	LigandsIBA 04/2024 - 02/2015
4	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2022 - 01/2013
4	salvinIBA 05/2015 - 04/2011
4	Interferon-gamma (Interferon, gamma)IBA 01/2014 - 08/2003
4	RNA (Ribonucleic Acid)IBA 01/2013 - 01/2007
3	Plasminogen Activator Inhibitor 1IBA 01/2022 - 04/2002
3	Chloroquine (Aralen)FDA LinkGeneric 12/2021 - 11/2017
3	AcidsIBA 01/2021 - 06/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 02/2007
3	Pattern Recognition ReceptorsIBA 12/2012 - 02/2011
3	EdaravoneIBA 04/2011 - 12/2007
3	Nerve Growth Factor (NGF)IBA 04/2011 - 01/2005
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2007 - 05/2004
3	alpha-SynucleinIBA 06/2007 - 06/2002
2	NF-kappa B (NF-kB)IBA 04/2024 - 01/2007
2	tryptanthrineIBA 10/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2019
2	Antimalarials (Antimalarial Agents)IBA 12/2021 - 04/2019
2	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 09/2021 - 01/2006
2	Rituximab (Mabthera)FDA Link 01/2021 - 10/2017
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2021 - 10/2017
2	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 11/2019
2	Vitamin K FDA Link 01/2020 - 11/2019
2	Interleukin-8 (Interleukin 8)IBA 01/2020 - 01/2007
2	EnzymesIBA 01/2019 - 02/2015
2	ImmunosorbentsIBA 01/2019 - 02/2015
2	gnetin CIBA 01/2018 - 01/2018
2	ResveratrolIBA 01/2018 - 01/2018
2	Chemotactic FactorsIBA 01/2018 - 01/2014
2	Toll-Like Receptor 4IBA 08/2017 - 08/2013
2	CholesterolIBA 01/2017 - 10/2009
2	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2017 - 02/2008
2	Small Interfering RNA (siRNA)IBA 01/2016 - 09/2011
2	IronIBA 05/2015 - 08/2003
2	Deferoxamine (Desferal)FDA LinkGeneric 05/2015 - 08/2003
2	Chelating AgentsIBA 05/2015 - 08/2003
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2015 - 01/2014
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2014 - 02/2013
2	mizoribineIBA 01/2014 - 12/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014 - 12/2013
2	ChromatinIBA 12/2007 - 01/2007
2	Talaporfin (talaporfin sodium)IBA 07/2007 - 01/2006
2	Photosensitizing Agents (Photosensitizers)IBA 07/2007 - 01/2006
2	Plasminogen Activators (Plasminogen Activator)IBA 08/2003 - 04/2002
1	resiquimodIBA 04/2024
1	Indigo Carmine (Indigo Blue)IBA 03/2023

Therapy/Procedure

5	Therapeutics 10/2017 - 01/2006
2	Photochemotherapy (Photodynamic Therapy) 07/2007 - 01/2006